Curaleaf Holdings (TSX:CURA) has added new dispensaries in Riverview and Cutler Bay in Florida, along with a storefront in downtown Boston, putting fresh attention on how this expansion could influence the stock.
Curaleaf Holdings’ latest dispensary openings come at a time when the CA$13.72 share price has a 1-day share price return of 4.10%, a 30-day share price return of 5.95%, and a year-to-date share price return of 27.75%. The 1-year total shareholder return of 14.91% contrasts with weaker 3-year and 5-year total shareholder returns, suggesting recent momentum has picked up after a tougher few years for longer term holders.
Spot opportunities that echo Curaleaf Holdings' recent momentum by checking companies on our 9 high quality undiscovered gems with strong fundamentals that may be flying under most investors' radar.Curaleaf Holdings now has a wider footprint and a share price that has moved higher in the short term. The business reach looks stronger. The next question is whether CA$13.72 still reflects a fair price.
The most followed Curaleaf Holdings narrative points to a fair value of CA$18.54, compared with the current CA$13.72 share price, and anchors that view on revenue growth, margin gains and a future earnings multiple.
Focused investment in R&D-driven product innovation, such as new premium oil extraction methods (ACE), proprietary vape devices, and expanded product lines (Anthem pre-rolls, new launches in Australia), positions Curaleaf to capture emerging health and wellness consumer trends, potentially boosting brand equity and supporting higher-margin product sales, thus improving net margins.
Curaleaf Holdings is being valued on a story built around faster revenue growth, higher future margins and a richer profit multiple. Want to see the exact mix of those moving pieces that underpins a higher fair value than today’s CA$13.72 price?
Result: Fair Value of CA$18.54 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Curaleaf Holdings still faces risks, including ongoing regulatory uncertainty and pricing pressure that could weigh on margins and challenge the current undervalued narrative.
Find out about the key risks to this Curaleaf Holdings narrative.
With both risks and rewards in play for Curaleaf Holdings, it helps to move quickly and review the details yourself before opinions settle. To weigh the full picture on potential upsides and concerns, start by checking the 4 key rewards and 3 important warning signs.
If you like the current setup for Curaleaf Holdings, do not stop here. Broaden your watchlist with a few targeted stock ideas that could sharpen your next decision.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com